CHAL — Chalice Brands Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMicro Cap
2016 December 31st | R2017 December 31st | R2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.66 | 11.5 | 14.7 | 15.8 | 21.9 |
Cost of Revenue | |||||
Gross Profit | -0.21 | 1.51 | 0.909 | 4.3 | 7.01 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26.1 | 39.3 | 32.7 | 45 | 28.4 |
Operating Profit | -18.5 | -27.8 | -18 | -29.3 | -6.51 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.4 | -56.3 | -4.19 | -31.8 | -9.07 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.3 | -56.5 | -4.28 | -32.6 | -10 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -21.3 | -56.5 | -4.57 | -46.4 | -10 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.3 | -56.5 | -4.57 | -46.4 | -10 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.02 | -3.92 | -0.243 | -0.737 | -0.239 |